Up | AC
Home Page
Food and
Drug Administration
Joint Meeting of the
Peripheral and Central Nervous Drugs Advisory Committee and the
Psychopharmacologic Drugs Advisory Committee
July 10, 2008
BRIEFING INFORMATION
FDA
Disclaimer
Portions of this document have been determined to be exempt
from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. §
552).
FDA Briefing Material - Complete Review (pdf) (added 7/7/08)
FDA Briefing Material - Statistical Review (pdf)
Pfizer
Disclaimer
The statements contained in this document(s) are those of
the product's sponsor, not FDA, and FDA does not necessarily
agree with the sponsor's statements. FDA has not made a final
determination about the safety or effectiveness of the product
described in this document.
Briefing Document (pdf) (added 7/9/08)